Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Samson

Showing results (121-130 of 181) with videos related to

Pageof 19
Sort By:
Scientific Reports|October 17, 2025
Mature CD209<sup>+</sup>CD83<sup>+</sup>CCR7<sup>+</sup> dendritic cells infiltrate the arterial wall in giant cell arteritis and derive from in-situ monocyte differentiationAndré Ramon, Hélène Greigert, Baptiste Lamarthée, et al.
Presse Medicale (Paris, France : 1983)|October 8, 2013
Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitidesPierre Charles, Boris Bienvenu, Bernard Bonnotte, et al.
Frontiers in Immunology|March 29, 2017
T Cell Polarization toward T<sub>H</sub>2/T<sub>FH</sub>2 and T<sub>H</sub>17/T<sub>FH</sub>17 in Patients with IgG4-Related DiseaseAurélie Grados, Mikael Ebbo, Christelle Piperoglou, et al.
Journal of Autoimmunity|October 2, 2019
Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factorThibault Maillet, Tiphaine Goletto, Guillaume Beltramo, et al.
Seminars in Arthritis and Rheumatism|February 17, 2026
Stroke characteristics in giant cell arteritis and Takayasu arteritis: A multicenter retrospective cohort study of 108 patientsOmar Dhrif, Charlotte Caudron, Simon Parreau, et al.
La Revue De Medecine Interne|November 1, 2024
French protocol for the diagnosis and management of giant cell arteritisHubert de Boysson, Valérie Devauchelle-Pensec, Christian Agard, et al.
Blood|August 22, 2013
Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopeniaSylvain Audia, Maxime Samson, Matthieu Mahévas, et al.
Rheumatology (Oxford, England)|April 9, 2021
Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case-control and exploratory studyMatthias Papo, Chloé Friedrich, Laure Delaval, et al.
Seminars in Arthritis and Rheumatism|February 21, 2023
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosisVictor Genin, Jean-François Alexandra, Hubert de Boysson, et al.
European Journal of Internal Medicine|April 16, 2024
Prognostic value of 18 FDG-PET at diagnosis and follow-up in giant cell arteritis: An observational restrospective studyAnne-Claire Billet, Thomas Thibault, Éric Liozon, et al.
Pageof 19

Showing results (121-130 of 181) with videos related to

Sort By:
Pageof 19
Scientific Reports|October 17, 2025
Mature CD209<sup>+</sup>CD83<sup>+</sup>CCR7<sup>+</sup> dendritic cells infiltrate the arterial wall in giant cell arteritis and derive from in-situ monocyte differentiationAndré Ramon, Hélène Greigert, Baptiste Lamarthée, et al.
Presse Medicale (Paris, France : 1983)|October 8, 2013
Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitidesPierre Charles, Boris Bienvenu, Bernard Bonnotte, et al.
Frontiers in Immunology|March 29, 2017
T Cell Polarization toward T<sub>H</sub>2/T<sub>FH</sub>2 and T<sub>H</sub>17/T<sub>FH</sub>17 in Patients with IgG4-Related DiseaseAurélie Grados, Mikael Ebbo, Christelle Piperoglou, et al.
Journal of Autoimmunity|October 2, 2019
Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factorThibault Maillet, Tiphaine Goletto, Guillaume Beltramo, et al.
Seminars in Arthritis and Rheumatism|February 17, 2026
Stroke characteristics in giant cell arteritis and Takayasu arteritis: A multicenter retrospective cohort study of 108 patientsOmar Dhrif, Charlotte Caudron, Simon Parreau, et al.
La Revue De Medecine Interne|November 1, 2024
French protocol for the diagnosis and management of giant cell arteritisHubert de Boysson, Valérie Devauchelle-Pensec, Christian Agard, et al.
Blood|August 22, 2013
Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopeniaSylvain Audia, Maxime Samson, Matthieu Mahévas, et al.
Rheumatology (Oxford, England)|April 9, 2021
Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case-control and exploratory studyMatthias Papo, Chloé Friedrich, Laure Delaval, et al.
Seminars in Arthritis and Rheumatism|February 21, 2023
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosisVictor Genin, Jean-François Alexandra, Hubert de Boysson, et al.
European Journal of Internal Medicine|April 16, 2024
Prognostic value of 18 FDG-PET at diagnosis and follow-up in giant cell arteritis: An observational restrospective studyAnne-Claire Billet, Thomas Thibault, Éric Liozon, et al.
Pageof 19